Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamad Navab

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Lipidology|July 1, 2014
Apolipoprotein A-I mimeticsSrinivasa T Reddy, Mohamad Navab, Gattadahalli M Anantharamaiah, et al.
Current Atherosclerosis Reports|December 16, 2006
Modifying the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Mohamad Navab, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis preventionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Biochimica Et Biophysica Acta|January 28, 2014
Searching for a successful HDL-based treatment strategySrinivasa T Reddy, Mohamad Navab, G M Anantharamaiah, et al.
Atherosclerosis|May 9, 2002
Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjectsMaziar Rahmani, Farbod Raiszadeh, Sima Allahverdian, et al.
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|July 20, 2004
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activityDaoguang Yan, Mohamad Navab, Can Bruce, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2006
Understanding changes in high density lipoproteins during the acute phase responseBrian J Van Lenten, Srinivasa T Reddy, Mohamad Navab, et al.
Current Opinion in Lipidology|March 12, 2009
Dyslipidemia and cardiovascular diseasesHoma Mahdavi, Juyong Brian Kim, Scheila Safarpour, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a)Mohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Lipidology|July 1, 2014
Apolipoprotein A-I mimeticsSrinivasa T Reddy, Mohamad Navab, Gattadahalli M Anantharamaiah, et al.
Current Atherosclerosis Reports|December 16, 2006
Modifying the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell, Gregg C Fonarow, Mohamad Navab, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis preventionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Biochimica Et Biophysica Acta|January 28, 2014
Searching for a successful HDL-based treatment strategySrinivasa T Reddy, Mohamad Navab, G M Anantharamaiah, et al.
Atherosclerosis|May 9, 2002
Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjectsMaziar Rahmani, Farbod Raiszadeh, Sima Allahverdian, et al.
Nature Reviews. Cardiology|February 10, 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanismsMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Journal of Lipid Research|July 20, 2004
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activityDaoguang Yan, Mohamad Navab, Can Bruce, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2006
Understanding changes in high density lipoproteins during the acute phase responseBrian J Van Lenten, Srinivasa T Reddy, Mohamad Navab, et al.
Current Opinion in Lipidology|March 12, 2009
Dyslipidemia and cardiovascular diseasesHoma Mahdavi, Juyong Brian Kim, Scheila Safarpour, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a)Mohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.
Pageof 15